Guide

Peptide Dosing Guide and Reconstitution Reference

A peptide dosing guide and peptide dosage chart for licensed professionals: units, concentration math and reconstitution reference.

Reconstitution & Dosing

An Introduction to Peptide Reconstitution and Dosing

Disclaimer: This guide is provided exclusively for licensed medical professionals as a general reference. It is not intended to serve as medical advice, diagnosis, or treatment, nor should it replace professional clinical judgment. The material herein is not designed to direct or dictate patient care.

An Introduction to Peptide Reconstitution and Dosing

Accurate dosing is critical for safety, efficacy, and patient outcomes, and this manual serves as a foundational resource for healthcare providers utilizing these advanced therapeutic compounds.

Understanding the distinctions between milligrams (mg), milliliters (mL), and units is essential:

mg (Milligrams) refer to the total amount of active peptide contained within a vial.

mL (Milliliters) is the volume used for reconstitution, typically using Bacteriostatic Water containing Benzyl Alcohol. One mL is equivalent to 100 units on a standard insulin syringe.

Units are the actual dosing measurements used when drawing and administering peptides via syringe.

Throughout this manual, you may encounter dosing ranges such as 10 to 40 units per day. It is important to understand that more is not better. Start low and titrate upward as needed. Peptide therapy is highly individualized. Each patient will respond differently and should be guided to find their ideal dosing range or “sweet spot” through careful tracking and adjustment.

Depending on the peptide, recommendations may include 6 weeks on followed by 4 weeks off, or 5 days on and 2 days off. These guidelines help optimize therapeutic benefit while minimizing tolerance or side effects. Please ensure that all instructions are clearly communicated to patients for safe and compliant use.

NOTE: It is recommended to reconstitute all lyophilized peptides with Bacteriostatic Water containing Benzyl (unless otherwise noted).

Weight

Weight

GLP-1 (S)

GLP-1 receptor against that regulates appetite and blood sugar, clinically proven for weight loss, improved insulin sensitivity, and metabolic health.

Peptide Dosage Chart

Amount In BottleBAC WATER INAMOUNT PER UNIT
5 mgx1 mLx0.05 mg
10 mgx2 mLx0.05 mg
20 mgx4 mLx0.05 mg
50 mgx5 mLx0.01 mg
Injection Type
Subcutaneous
Frequency
1x per week
Recommended Dose
Same day weekly injection
Cycle Length
Ongoing or as prescribed

Dosing Schedule For Maximum Efficacy

5mg / 10mg / 20mg – Titrate up from 5 to 50 units / 0.25 mg to 2.5 mg

50 mg – Titrate up from 2.5 to 25 units / 0.25 mg to 2.5 mg

Onset Of Effects

Week 1-2: Appetite reduction, earlier satiety

Week 3-4: Steady weight loss, improved glucose control

Week 6+: Continued fat loss, reduced cravings, stabilized insuline response

Weight

GLP-1 (T)

  • Dual GIP and GLP-1 receptor agonist — enhances insulin sensitivity, suppresses appetite, and significantly promotes fat loss.
  • Clinically more potent than semaglutide for metabolic health and weight management.

Reconstitution

Amount In BottleBAC WATER INAMOUNT PER UNIT
10 mgx1 mLx0.1 mg
30 mgx3 mLx0.1 mg
50 mgx3 mLx0.17 mg
60 mgx3 mLx0.2 mg
75 mgx3 mLx0.25 mg
100 mgx4 mLx0.25 mg
120 mgx5 mLx0.24 mg
Injection Type
Subcutaneous
Frequency
1x per week
Recommended Dose
Same day weekly injection
Cycle Length
Ongoing or as prescribed

Onset Of Effects

Week 1–2: Reduced hunger and cravings

Week 3–4: Noticeable weight loss, improved blood glucose control

Week 6+: Sustained fat loss, improved metabolic markers, increased energy

Dosing Schedule for Maximum Efficacy

10mg – Titrate up from 25 to 100 units / 2.5 mg to 10 mg

30mg – Titrate up from 25 to 150 units / 2.5 mg to 15 mg

50mg – Titrate up from 15 to 90 units / 2.5 mg to 15 mg

60mg – Titrate up from 12.5 to 75 units / 2.5 mg to 15 mg

75mg / 100mg – Titrate up from 10 to 60 units / 2.5 mg to 15 mg

120mg – Titrate up from 10 to 63 units / 2.5 mg to 15 mg

Weight

GLP-1 (R)

  • Triple agonist targeting GLP-1, GIP, and glucagon receptors — designed for powerful appetite suppression, metabolic improvement, and aggressive fat loss.
  • One of the most advanced weight management peptides in development.

Reconstitution

Amount In BottleBAC WATER INAMOUNT PER UNIT
12 mgx1.2 mLx0.1 mg
16 mgx1.6 mLx0.1 mg
24 mgx2.4 mLx0.1 mg
Injection Type
Subcutaneous
Frequency
1x per week
Recommended Dose
15 to 90 units / 2 mg–12 mg titrated slowly
Cycle Length
Ongoing or as prescribed

Dosing Schedule For Maximum Efficacy

Once weekly, same day each week, with or without food.

Onset Of Effects

Week 1–2: Suppressed appetite, less frequent eating

Week 3–4: Rapid fat loss, improved insulin and glucose response

Week 6+: Sustained weight reduction, improved body composition

Weight

GLP-1 (R)

  • Triple agonist targeting GLP-1, GIP, and glucagon receptors — designed for powerful appetite suppression, metabolic improvement, and aggressive fat loss.
  • One of the most advanced weight management peptides in development.

Reconstitution

Amount In BottleBAC WATER INAMOUNT PER UNIT
40 mgx2 mLx0.2 mg
Injection Type
Subcutaneous
Frequency
1x per week
Recommended Dose
10 to 60 units / 2 mg–12 mg titrated slowly
Cycle Length
Ongoing or as prescribed

Dosing Schedule For Maximum Efficacy

Once weekly, same day each week, with or without food.

Onset Of Effects

Week 1–2: Suppressed appetite, less frequent eating

Week 3–4: Rapid fat loss, improved insulin and glucose response

Week 6+: Sustained weight reduction, improved body composition

Weight

GLP-1 (R)

  • Triple agonist targeting GLP-1, GIP, and glucagon receptors — designed for powerful appetite suppression, metabolic improvement, and aggressive fat loss.
  • One of the most advanced weight management peptides in development.

Reconstitution

Amount In BottleBAC WATER INAMOUNT PER UNIT
60 mgx4.5 mLx0.133 mg
Injection Type
Subcutaneous
Frequency
1x per week
Recommended Dose
15 to 90 units / 2 mg–12 mg titrated slowly
Cycle Length
Ongoing or as prescribed

Dosing Schedule For Maximum Efficacy

Once weekly, same day each week, with or without food.

Onset Of Effects

Week 1–2: Suppressed appetite, less frequent eating

Week 3–4: Rapid fat loss, improved insulin and glucose response

Week 6+: Sustained weight reduction, improved body composition

Weight

CAGRILINTIDE

  • A powerful peptide for appetite control, Weight Loss, and metabolic support.

Reconstitution

Amount In BottleBAC WATER INAMOUNT PER UNIT
10 mgx2 mLx0.05 mg
Injection Type
Subcutaneous
Frequency
1x per week
Recommended Dose
6 to 90 units / 300 mcg to 4.5 mg
Cycle Length
16-24 weeks on, 2 weeks off

Dosing Schedule For Maximum Efficacy

Once weekly, same day each week, with or without food.

Onset Of Effects

Begin with low dose to minimize nausea, gradually increasing to recommended dose

Can be combined with GLP-1 medications for enhanced results Stacking improves appetite control and fat loss synergy

Weight

CAGRILINTIDE 5mg | GLP-1 S 5mg

  • Dual appetite control
  • Reduces hunger and cravings while promoting satiety
  • Supports metabolic balance and blood sugar stability

Reconstitution

Amount In BottleBAC WATER INAMOUNT PER UNIT
10 mgx2 mLx0.05 mg
Injection Type
Subcutaneous
Frequency
1x per week
Recommended Dose
5 to 50 units / .25 mg to 2.5 mg
Cycle Length
16-24 weeks on, 2 weeks off

Dosing Schedule For Maximum Efficacy

Once weekly, same day each week, fasted.

Onset Of Effects

Begin with low dose to minimize nausea, gradually increasing to recommended dose

First 24–72 hours: Many people notice reduced appetite, smaller portions, and decreased snacking. It’s often subtle at first.

Week 1–2: Full satiety effect becomes more noticeable. Food noise drops significantly.

Week 3–4: Most people reach steady, predictable appetite suppression.

Weight

HCG

  • Mimics luteinizing hormone (LH)
  • Used to stimulate natural testosterone production, preserve fertility, and support testicular function
  • Supports muscle growth, maintaining bone density, and helps regulate metabolism.

Reconstitution

Amount In BottleBAC WATER INAMOUNT PER UNIT
10,000 IUx2 mLx50 IU per unit
Injection Type
Subcutaneous
Frequency
2x per week
Recommended Dose
10 to 20 units / 500 IU to 1,000 IU
Cycle Length
4–12 weeks, depending on use case

Dosing Schedule For Maximum Efficacy

Morning or post-workout, fasted – 45 min before and after injection.

Onset Of Effects

Within 1–2 weeks — increased libido, improved mood, and testicular fullness.

Notes

Blood testosterone levels typically rise within 2–3 weeks of consistent use.